Confused about which emollient to recommend?

No other emollient treats more dry skin conditions than E45 Cream* View in browser No other emollient treats more dry skin conditions than E45 Cream* 60 per cent of British people currently suffer from or have suffered with a skin disease at some point during their lifetime.1 Dry skin conditions can present similar symptoms; your customer may find distinguishing between different dry skin conditions somewhat difficult. The vast range of treatments available can add to their confusion. This provides an opportunity for you and your pharmacy team to help customers take control of their skin health with straightforward advice and the proven efficacy of E45. Visit our mini-module to learn more E45 Cream is licensed for treatment of most dry skin conditions such as: Dry/flaky skin Eczema Ichthyosis Dermatitis Chapped skin Dry posriasis† Sunburn Itchy skin. Gets to work instantly and improves dry skin health at every application Significantly reduced symptom severity A study showed that using E45 Cream three times a day over 12 weeks can significantly reduce the severity of atopic eczema symptoms in children with mild-to-moderate eczema and help improve their quality of life.2 Your intervention can help Another study showed that a nurse's intervention can also help reduce the severity of atopic eczema by up to 89% in children.3 RECOMMEND E45 CREAM. APPLY 3 TIMES A DAY FOR DRY SKIN CONDITIONS. LEARN MORE *For verification please write to PO BOX 4044, Slough, SL1 0NS. †Certain cases of Dry Psoriasis. REFERENCES:   1) British Skin Foundation. Who we are. Accessed May 2020. https://www.britishskinfoundation.org.uk/who-we-are 2) Mason, J., Carr, J., Buckley, C., Hewitt, S., Berry, P., Taylor, J. and Cork, M. 2013. Improved emollient use reduces atopic eczema symptoms and is cost neutral in infants: before-and-after evaluation of a multifaceted educational support programme. BMC Dermatology, 13(1). 3) Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. 2003. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol, 149:582–589. ESSENTIAL INFORMATION: E45 Cream. Active Ingredient: White Soft Paraffin 14.5% w/w, Light Liquid Paraffin 12.6% w/w and Anhydrous Lanolin 1.0% w/w. Indications: For the symptomatic relief of dry skin conditions, where the use of an emollient is indicated, such as flaking, chapped skin, ichthyosis, traumatic dermatitis, sunburn, the dry stage of eczema and certain dry cases of psoriasis. Dosage and administration: Adults, the elderly, children and infants over the age of 1 month - apply to the affected part two or three times daily. Contra-indications: E45 Cream should not be used by patients with hypersensitivity to white soft paraffin, liquid light paraffin and anhydrous lanolin or to any of the excipients. Precautions and Warnings: If a rash develops, use of the product should be discontinued. Instruct patients not to smoke or go near naked flames – risk of severe burns. Fabric (clothing, bedding, dressings etc) that has been in contact with this product burns more easily and is a serious fire hazard. Washing clothing and bedding may reduce product build-up but not totally remove it. Fertility, Pregnancy and Lactation: No effects during pregnancy are anticipated, since systemic exposure to white soft paraffin, liquid paraffin and lanolin is negligible. As with all medicines, this product should be used with caution during pregnancy. It is unknown whether soft paraffin, light liquid paraffin and anhydrous lanolin metabolites are excreted in human milk. A risk to the newborns/ infants cannot be excluded. Application of the product to the breast is not recommended during breast feeding. No data on human fertility are available. Side effects: Occasionally, hypersensitivity reactions, otherwise adverse effects are unlikely. Should this occur, use of the product should be discontinued. For a full information of adverse reactions, see SmPC. Product licence number: PL 00063/0404.Product licence holder: Reckitt Benckiser Healthcare (UK) Ltd, Slough, SL1 4AQ, UK. Legal category: GSL. MRRP: £2.99 50g, £4.99 125g, 8.99 350g £11.49 500g, pump £12.49 500g (excl VAT). Date of preparation: April 2020 - For full information refer to SmPC (https://www.medicines.org.uk/emc/medicine/21988) Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Reckitt Benckiser Healthcare (UK) Ltd on: 0333 200 5345. RB-M-06036. Date of preparation: June 2020. Pharmacy Magazine is part of the Pharmacy Network, a learning system developed and operated by Communications International Group, the UK's largest provider of community pharmacy learning content.   We are sending you this alert on behalf of one of our valued partners. Should you not wish to continue to receive these alerts simply click unsubscribe below. Unsubscribe   Ι  Contact  Ι  Privacy Policy  Ι  Become a Member